Most Recent
Construction PRO
The managing director of the Australian arm of property developer Arada has lost his bid to bar a vote on his termination as he and the group's CEO sling allegations of misconduct and dishonesty.
Construction PRO
Two units of builder BGC have won a stay of building remedy orders to re-pipe homes fitted with faulty Iplex piping while they appeal the orders, but have lost a bid to adjourn the appeals.
The board administering the ESSSuper fund, which is facing a class action alleging it miscalculated the entitlements of transport shift workers in Victoria, has denied any liability, saying it was not involved in determining how entitlements were calculated.
Andrew ‘Twiggy’ Forrest’s Fortescue can't get access to nine million seized documents in its trade secrets spat against green iron start-up Element Zero.
Construction PRO
Spanish infrastructure firm Acciona is mulling cross-claims against contractor Veolia Australia after losing its fight to move their dispute over the Kwinana waste-to-energy project west, a court has heard.
The Australian Competition and Consumer Commission has cleared the way for ASX-listed Cuscal's to acquire payment facilitation supplier Indue, saying it was unlikely to substantially lessen competition.
Construction PRO
Infrastructure giant Acciona must fight a $224M lost-revenue case by contractor Veolia Australia over the Kwinana waste-to-energy plant on Veolia's home turf.
Construction PRO
The competition regulator is seeking to intervene in Mayfield Development's appeal to the High Court in a case the developer says could have "startling" consequences.
Having lost a challenge to privatisation agreements by NSW Ports, the competition regulator wants to intervene in a High Court appeal by Mayfield Developments, which failed in its own case against the port authority.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.